Uptake and binding of catecholamines. Effect of diphenylhydantoin and a new mechanism of action.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism; D000818:Animals; D001479:Basal Ganglia / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002247:Carbon Isotopes; D002421:Caudate Nucleus / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D007031:Hypothalamus / Q000378:metabolism; D000860:Hypoxia / Q000378:metabolism; D008297:Male; D008854:Microscopy, Electron; D008861:Microsomes / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D010672:Phenytoin / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D012640:Seizures / Q000188:drug therapy; D013572:Synaptic Vesicles / Q000378:metabolism; D014316:Tritium; D014882:Water-Electrolyte Balance
D002247:Carbon Isotopes; D014316:Tritium; D010672:Phenytoin; D000251:Adenosine Triphosphatases; D004298:Dopamine; D009638:Norepinephrine